© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Alexa can now securely transmit and receive personalized medical information.
HIV is associated with an elevated risk of diabetes.
HIV-positive individuals tend to develop frailty at a younger age than the general population.
This from a small study of people who switched from a boosted protease inhibitor to Isentress (raltegravir) or Tivicay (dolutegravir).
Non-alcoholic fatty liver disease can lead to more severe, potentially fatal liver diseases, including cirrhosis.
However, while HbA1c and fasting glucose levels decline after a hep C cure, the clinical significance of such shifts remains unclear.
A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.
This is according to an analysis of multiple factors potentially related to a diabetes diagnosis in a large group of French people with HIV.
As treatment of the virus has improved among women with HIV, type 2 diabetes care lags far behind.
More of those living with HIV are developing diabetes.
Compared with their HIV-negative peers, HIV-positive individuals have higher rates of treatment for a host of health problems.
A recent study found that the virus was associated with abdominal obesity as well as high triglycerides and low LDL cholesterol.
People with the virus are living longer and are thus more likely to develop diabetes—plus certain HIV meds may also raise the risk.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
